Skip to main content

MoneyWorks4Me

Shilpa Medicare informs about updates

28 Jul 2021 Evaluate

Shilpa Medicare has informed today about the receipt of confirmation of WHO-GENEVA approval for API, Tenofovir Disoproxil Fumarate, a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS, under pre-qualification program.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..